REC610
Herpes Zoster (Shingles)
Phase 3Active
Key Facts
About Recbio Technology
A Chinese vaccine innovator with proprietary adjuvant and protein engineering platforms, advancing late-stage HPV and shingles vaccines.
View full company profileTherapeutic Areas
Other Herpes Zoster (Shingles) Drugs
| Drug | Company | Phase |
|---|---|---|
| Anti-VZV Program | Pagari Life Science | Pre-clinical |